Canadian radioisotope developer MDS Nordion, a division of Toronto-based MDS, reported a decrease in revenues for its fiscal 2006 fourth quarter (end-October 31), although the fiscal year showed positive growth.
MDS Nordion reported revenue for its fourth quarter of $85 million Canadian ($73.52 million U.S.), down 11% from last year's fourth-quarter revenues of $96 million ($83.04 million).
For the full year, revenues grew by 4% to $338 million ($292.4 million) in fiscal 2006 from $325 million ($281.2 million) in fiscal 2005, according to the Kanata, Ontario-based firm.
MDS Nordion said that its overall revenue growth for the year was driven principally by incremental volumes in its cardiac imaging business.
By AuntMinnie.com staff writers
December 14, 2006
Related Reading
MDS sells diagnostics unit, October 5, 2006
MDS Nordion gets FDA OK for TheraSphere clinical trials, September 26, 2006
MDS Nordion Q3 posts flat revenues, September 7, 2006
MDS Nordion Q2 shows gains, June 8, 2006
MDS Nordion moves closer to end users, June 7, 2006
Copyright © 2006 AuntMinnie.com
